D. E. Shaw & Co., Inc. Bioventus Inc. Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 70,442 shares of BVS stock, worth $505,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,442
Previous 167,751
58.01%
Holding current value
$505,069
Previous $1.53 Million
69.62%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BVS
# of Institutions
144Shares Held
49.5MCall Options Held
85.1KPut Options Held
13K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$93.4 Million30.91% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$49.8 Million19.48% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.28MShares$37.9 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$20.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $442M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...